Eradication and follow-up of Helicobacter pylori infection in hemodialysis patients.
It is currently accepted that Helicobacter pylori (Hp) infection is crucial in the pathogenesis of peptic ulcer. Therefore, we developed a prospective study to assess the prevalence of Hp infection by the 13C Urea Breath Test (13C UBT) in 52 hemodialysis patients, and we evaluated the efficacy of two consecutive eradication regimens in 23 positive patients with dyspepsia and/or on a transplantation list. The correlation between anti-Hp serology and 13C UBT results was also analyzed in 34 patients who were followed up during 18 months. The Hp prevalence by 13C UBT was 63.5% (33/52). The eradication rate after the first cycle of therapy (amoxicillin 500 mg/8 h and omeprazole 20 mg/12 h, 14 days) was 60.8% (14/23). After the second cycle (clarithromycin 500 mg/12 h plus omeprazole 20 mg/12 h, 14 days), the eradication rate reached 82.6% (19/23). The serological procedure showed a good correlation with 13C UBT (about 80% sensitive and specific) when very restrictive diagnostic and eradication criteria were adopted. We conclude that an eradication rate higher than 80% can be reached after two consecutive cycles of dual therapy in hemodialysis patients. Anti-Hp serological tests must be cautiously interpreted in these patients.
Muñoz de Bustillo
E
E
Department of Nephrology, Hospital Universitario de la Princesa, Madrid, Spain.
Sánchez Tomero
J A
JA
Sanz
J C
JC
Moreno
J A
JA
Jiménez
I
I
López-Brea
M
M
Pajares
J M
JM
Traver
J A
JA
D000368:Aged; D001944:Breath Tests; D002247:Carbon Isotopes; D005260:Female; D016481:Helicobacter Infections / Q000175:diagnosis*; D016480:Helicobacter pylori / Q000472:pathogenicity*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000382:microbiology; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012699:Serology; D014508:Urea / Q000032:analysis
D002247:Carbon Isotopes; D014508:Urea